Corina van den Hurk

Netherlands Comprehensive Cancer Organisation

Corina van den Hurk is an occupational therapist who studied health science at Maastricht University in the Netherlands, with a master degree in movement science and epidemiology. After graduation she worked at the Comprehensive Cancer Centre the Netherlands, first as a cancer registrar and thereafter as a researcher on a project on quality of care in breast cancer.

She started research on scalp cooling at Leiden University Medical Centre and the Comprehensive Cancer Centre the Netherlands in 2005 and finished her PhD on scalp cooling in 2013.

From 2009 to 2013 she was also assistant coordinator of the EU-FP7 project EUROpe against Cancer: Optimisation of the Use of Registries for Scientific Excellence in research (EUROCOURSE).

dont miss

Hair loss through chemotherapy is not inevitable!

Chemotherapy-induced alopecia is a side effect with high impact for many cancer patients. In Europe scalp cooling has been used to prevent hair loss for over a decade and is increasingly being applied worldwide. A registry containing data of more than 5,000 scalp cooled breast cancer patients shows varying success rates depending on type and dose of chemotherapy. Determinants of efficacy as well as safety and cost-effectiveness will be discussed.


  • Luca Boldrini: Speaking at the Oncology Convention

    Luca Boldrini
    Università Cattolica del Sacro Cuore, Roma, Italia

    Radiomics applications rectal cancer: the MRIdian perspective

  • Gabrielle Zamagias: Speaking at the Oncology Convention

    Gabrielle Zamagias

    Remote Patient Monitoring: Bringing the Hospital into the Home

  • Joanne Edwards: Speaking at the Oncology Convention

    Joanne Edwards
    University of Glasgow

    Role of IKK alpha in Breast Cancer

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development

  • Dr Antonia Lavorata: Speaking at the Oncology Convention

    Dr Antonia Lavorata

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment